Daily blood tests could personalize lung cancer treatment timing
NCT ID NCT07190027
Summary
This study aims to see if adjusting the timing of immunotherapy based on daily blood tests improves treatment for adults with advanced non-small cell lung cancer. Researchers will compare giving immunotherapy on the same day as chemotherapy, on a fixed later day, or on a personalized day chosen by monitoring the patient's immune response. The goal is to find the safest and most effective schedule to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.